PMC:7204657 / 790-951 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"25","span":{"begin":125,"end":133},"obj":"Species"},{"id":"30","span":{"begin":40,"end":51},"obj":"Chemical"},{"id":"31","span":{"begin":144,"end":155},"obj":"Chemical"}],"attributes":[{"id":"A25","pred":"tao:has_database_id","subj":"25","obj":"Tax:9606"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"MESH:C502936"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"MESH:C502936"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"light a rare but feared complication of tocilizumab: intestinal perforation [2]. The mechanism for intestinal perforation in patients receiving tocilizumab is no"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T5","span":{"begin":53,"end":63},"obj":"Body_part"},{"id":"T6","span":{"begin":99,"end":109},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma7199"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma7199"}],"text":"light a rare but feared complication of tocilizumab: intestinal perforation [2]. The mechanism for intestinal perforation in patients receiving tocilizumab is no"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T11","span":{"begin":53,"end":75},"obj":"Disease"},{"id":"T12","span":{"begin":99,"end":121},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0006807"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0006807"}],"text":"light a rare but feared complication of tocilizumab: intestinal perforation [2]. The mechanism for intestinal perforation in patients receiving tocilizumab is no"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T6","span":{"begin":6,"end":7},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T7","span":{"begin":53,"end":63},"obj":"http://purl.obolibrary.org/obo/UBERON_0000160"},{"id":"T8","span":{"begin":53,"end":63},"obj":"http://www.ebi.ac.uk/efo/EFO_0000834"},{"id":"T9","span":{"begin":99,"end":109},"obj":"http://purl.obolibrary.org/obo/UBERON_0000160"},{"id":"T10","span":{"begin":99,"end":109},"obj":"http://www.ebi.ac.uk/efo/EFO_0000834"}],"text":"light a rare but feared complication of tocilizumab: intestinal perforation [2]. The mechanism for intestinal perforation in patients receiving tocilizumab is no"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":40,"end":51},"obj":"Chemical"},{"id":"T7","span":{"begin":144,"end":155},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"}],"text":"light a rare but feared complication of tocilizumab: intestinal perforation [2]. The mechanism for intestinal perforation in patients receiving tocilizumab is no"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T5","span":{"begin":53,"end":75},"obj":"Phenotype"},{"id":"T6","span":{"begin":99,"end":121},"obj":"Phenotype"}],"attributes":[{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0031368"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0031368"}],"text":"light a rare but feared complication of tocilizumab: intestinal perforation [2]. The mechanism for intestinal perforation in patients receiving tocilizumab is no"}